Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome)
- PMID: 9504611
- DOI: 10.1097/00005537-199803000-00013
Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome)
Abstract
Several therapeutic approaches exist to treat gustatory sweating (Frey's syndrome) following parotidectomy. Because of the lack of effective treatment, a new therapeutic modality using botulinum toxin injections was presented previously by our group. The duration of the demonstrated positive effect was essentially unknown so far. Based on our experiences using this technique since December 1993, the purpose of this clinical investigation was to make an up-to-date report and demonstrate the duration of effect of BOTOX injections in patients with severe gustatory sweating. Nineteen patients with severe gustatory sweating have been treated with BOTOX by intracutaneous injections into the affected skin areas. The maximal follow-up time was 33 months. The results were obtained by interviews and controls using Minor's starch iodine test. In all treated cases (n = 19 patients, 22 treated sides) gustatory sweating ceased completely within 2 days. Side effects were absent. In 12 patients gustatory sweating reappeared. The mean duration of effect was 17.3 months (subjective personal communication of 18 patients). Findings show that intracutaneous injection of BOTOX is a highly effective, safe, and minimally invasive treatment of Frey's syndrome with long-lasting therapeutic effect.
Similar articles
-
[Botulinum toxin for treatment of gustatory sweating. A prospective randomized study].Mund Kiefer Gesichtschir. 2004 Nov;8(6):369-75. doi: 10.1007/s10006-004-0575-3. Epub 2004 Oct 29. Mund Kiefer Gesichtschir. 2004. PMID: 15517441 Clinical Trial. German.
-
[Effectiveness of botulinum toxin A in the treatment of gustatory sweating].Nervenarzt. 2001 Oct;72(10):787-90. doi: 10.1007/s001150170035. Nervenarzt. 2001. PMID: 11688180 Clinical Trial. German.
-
Frey's syndrome: treatment with botulinum toxin.J Laryngol Otol. 1997 Sep;111(9):839-44. doi: 10.1017/s0022215100138769. J Laryngol Otol. 1997. PMID: 9373550
-
Botulinum toxin for Frey's syndrome: a closer look at different treatment responses.J Laryngol Otol. 2012 Feb;126(2):185-9. doi: 10.1017/S0022215111002581. Epub 2011 Oct 3. J Laryngol Otol. 2012. PMID: 22018335 Review.
-
Frey's syndrome. Treatment with botulinum toxin.Curr Probl Dermatol. 2002;30:170-7. doi: 10.1159/000060675. Curr Probl Dermatol. 2002. PMID: 12471711 Review. No abstract available.
Cited by
-
BOTOX: Broadening the Horizon of Dentistry.J Clin Diagn Res. 2014 Dec;8(12):ZE25-9. doi: 10.7860/JCDR/2014/11624.5341. Epub 2014 Dec 5. J Clin Diagn Res. 2014. PMID: 25654058 Free PMC article. Review.
-
[Botulinum toxin for treatment of gustatory sweating. A prospective randomized study].Mund Kiefer Gesichtschir. 2004 Nov;8(6):369-75. doi: 10.1007/s10006-004-0575-3. Epub 2004 Oct 29. Mund Kiefer Gesichtschir. 2004. PMID: 15517441 Clinical Trial. German.
-
Surgical and conservative methods for restoring impaired motor function - facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing).GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005;4:Doc10. Epub 2005 Sep 28. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005. PMID: 22073058 Free PMC article.
-
[First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].HNO. 2004 Jan;52(1):53-6. doi: 10.1007/s00106-003-0844-8. Epub 2003 Jun 17. HNO. 2004. PMID: 14740116 German.
-
Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1963-7. doi: 10.1007/s00405-010-1305-0. Epub 2010 Jun 19. Eur Arch Otorhinolaryngol. 2010. PMID: 20563590
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical